Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Other Non-Current Liabilities (2016 - 2025)

Dexcom (DXCM) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $137.1 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 7.3% to $137.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $137.1 million through Dec 2025, down 7.3% year-over-year, with the annual reading at $137.1 million for FY2025, 7.3% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $137.1 million at Dexcom, down from $147.4 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $151.6 million in Q2 2025, with the low at $82.4 million in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $122.5 million, with a median of $128.8 million recorded in 2022.
  • The sharpest move saw Other Non-Current Liabilities skyrocketed 294.26% in 2021, then dropped 7.3% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $90.0 million in 2021, then surged by 42.56% to $128.3 million in 2022, then fell by 2.1% to $125.6 million in 2023, then rose by 17.75% to $147.9 million in 2024, then dropped by 7.3% to $137.1 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $137.1 million, $147.4 million, and $151.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.